CHOSA — Chosa Oncology AB Cashflow Statement
0.000.00%
Last trade - 00:00- SEK51.25m
- SEK44.81m
- SEK0.04m
Annual cashflow statement for Chosa Oncology AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | SAS | SAS | — | SAS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -47.5 | -61.9 | -41.1 | -23.5 | -9.71 |
| Amortisation | |||||
| Non-Cash Items | 3.81 | 7.58 | 8.11 | 22 | 0.81 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | -6.84 | 5.14 | 2.1 | 1.93 | 1.04 |
| Change in Accounts Receivable | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -50.5 | -49.1 | -30.9 | 1.2 | -7.87 |
| Capital Expenditures | — | — | — | 0 | — |
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | — | — | — | 15.1 | 0 |
| Sale of Business | |||||
| Cash from Investing Activities | — | — | — | 15.1 | 0 |
| Financing Cash Flow Items | — | — | — | — | -0.051 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.014 | 0.47 | 15 | -8.52 | 5.53 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -52 | -47.9 | -14.5 | 7.81 | -2.33 |